---
title: Improved survival of advanced melanoma patients receiving immunotherapy with
  concomitant antithrombotic therapy - A multicenter study on 2419 patients from the
  prospective skin cancer registry ADOReg
date: '2024-12-06'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39642845/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20241207173203&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSION: Our study indicates a positive prognostic effect of anticoagulant
  and antiplatelet concomitant medication in melanoma patients receiving ICI. Further
  studies are needed to confrim the cancer-related benefit of adding anticoagulation
  or platelet inhibition to ICI ...'
disable_comments: true
---
CONCLUSION: Our study indicates a positive prognostic effect of anticoagulant and antiplatelet concomitant medication in melanoma patients receiving ICI. Further studies are needed to confrim the cancer-related benefit of adding anticoagulation or platelet inhibition to ICI ...